Dr. Mireia Niso-Santano is a researcher at the University of Extremadura, Spain. She conducted her postdoctoral research at the Gustave Roussy Comprehensive Cancer Center in Paris.  Since joining the University of Extremadura, she has received a research contract from the Ramón y Cajal Programme in the PARK research group (CTS038), which belongs to the Department of Biochemistry and Molecular Biology and Genetics of the University of Extremadura, the University Institute of Biosanitary Research of Extremadura (INUBE) and the Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED). She is a member of SEFAGIA. Her current research is focused on studying metabolic alterations associated with neurodegeneration and searching for neuroprotective agents based on natural compounds.